|
|
|
Bispecific Antibodies, Novel Diagnostics and Therapeutics for the next Millennium
|
Immunocreations is a new Canadian biotechnology company specializing in diagnostics and therapeutics based on its platform bispecific monoclonal antibody technology. Founded in 1993, company provides the following line of products and services:
� Development of bispecific antibodies for diagnostics and therapeutics.
� Development of monoclonal antibodies and bispecific antibodies.
� Prototype immunoassay, research and development.
� Design of novel downstream process development.
� Biotechnology consulting with special reference to bispecific antibodies and cancer.
|
|
|
|
|
Company Profile
|
The main focus of the company is the development of novel bispecific and bi-functional antibodies. Bispecific antibodies are second generation monoclonal antibodies capable of cross-linking any two molecules, one a target and the other an effector molecule, in a uniform, reproducible and in a predetermined fashion. Such constructs with dual specificities or functions generate immunoprobes where every targeting molecule is attached to the signal generating or therapeutic moiety. These immunoprobes are hence embodied with the highest specific activity useful in second generation immunoassays and potent therapeutics.
|
|
|
|
|
Promoter's Profile
|
Dr. Mavanur R. Suresh, the founder, was formerly the Chief Scientist of Biomira Inc., for eight years. Early training was in the laboratory of Molecular Biology, Cambridge, U.K. with the Nobel laureate Dr. C.Milstein, generally considered the father of monoclonal antibody technology. Currently Dr. Suresh holds the MRC-Industry Chair in Immunoconjugates sponsored by Biomira Inc., at Faculty of Pharmacy and Pharmaceutical Sciences,, Edmonton, Canada. An agreement is in place for the sponsor to obtain first rights to the technology developed in the University for licensing and commercial development. Immunocreations plans to develop unique products as well as technologies not acquired by the above agreement, with appropriate licenses from the university.
|
|
|
|
|
|
|
|
